Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
14.17
+0.40 (2.90%)
Aug 13, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Vision Care | 2.74B | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Growth | 6.59% | Log In | Log In | Log In | Log In | Upgrade |
Surgical | 843.00M | Log In | Log In | Log In | Log In | Upgrade |
Surgical Growth | 9.06% | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals | 1.21B | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Growth | 14.18% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals | 969.00M | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Growth | 20.12% | Log In | Log In | Log In | Log In | Upgrade |
Devices | 1.80B | Log In | Log In | Log In | Log In | Upgrade |
Devices Growth | 8.56% | Log In | Log In | Log In | Log In | Upgrade |
OTC | 1.72B | Log In | Log In | Log In | Log In | Upgrade |
OTC Growth | 5.60% | Log In | Log In | Log In | Log In | Upgrade |
Branded and Other Generics | 281.00M | Log In | Log In | Log In | Log In | Upgrade |
Branded and Other Generics Growth | -5.28% | Log In | Log In | Log In | Log In | Upgrade |
Other Product | 17.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Growth | 18.75% | Log In | Log In | Log In | Log In | Upgrade |
Capex by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Vision Care Capital Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Capital Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Capital Expenditures | - | Log In | Log In | Log In | Log In | Upgrade |
Corporate Capital Expenditures Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Vision Care Segment Profit | 808.00M | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Segment Profit Growth | 11.52% | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Profit | 44.00M | Log In | Log In | Log In | Log In | Upgrade |
Surgical Segment Profit Growth | -46.67% | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Segment Profit | 256.00M | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Segment Profit Growth | -32.95% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Segment Profit | -614.00M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Segment Profit Growth | 12.37% | Log In | Log In | Log In | Log In | Upgrade |
Amortization of Intangible Assets | -288.00M | Log In | Log In | Log In | Log In | Upgrade |
Amortization of Intangible Assets Growth | -0.36% | Log In | Log In | Log In | Log In | Upgrade |
Net Other Expense | -44.00M | Log In | Log In | Log In | Log In | Upgrade |
Net Other Expense Growth | -8.45% | Log In | Log In | Log In | Log In | Upgrade |
Other | 44.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -8.45% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
U.S. and Puerto Rico | 2.41B | Log In | Log In | Log In | Log In | Upgrade |
U.S. and Puerto Rico Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Total International | 2.38B | Log In | Log In | Log In | Log In | Upgrade |
Total International Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Vision Care Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Organic Change | - | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Organic Change Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Revenue Change in Constant Currency | 10.00 | Log In | Log In | Log In | Log In | Upgrade |
Vision Care Revenue Change in Constant Currency Growth | -31.71% | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Change in Constant Currency | 11.00 | Log In | Log In | Log In | Log In | Upgrade |
Surgical Revenue Change in Constant Currency Growth | 30.00% | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Change in Constant Currency | 17.00 | Log In | Log In | Log In | Log In | Upgrade |
Total Revenue Change in Constant Currency Growth | -43.28% | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Change in Constant Currency | 45.00 | Log In | Log In | Log In | Log In | Upgrade |
Ophthalmic Pharmaceuticals Revenue Change in Constant Currency Growth | -57.22% | Log In | Log In | Log In | Log In | Upgrade |